Globus Medical Inc (GMED)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 622,766 | 410,424 | 354,062 | 467,292 | 279,620 |
| Marketable Securities | 71,940 | 82,509 | 80,408 | 50,497 | 189,314 |
| Receivables | 593,196 | 614,282 | 534,699 | 504,870 | 495,852 |
| Inventories | 717,703 | 770,463 | 816,196 | 848,135 | 904,977 |
| TOTAL | $2,056,529 | $1,923,891 | $1,828,574 | $1,915,374 | $1,917,337 |
| Non-Current Assets | |||||
| PPE Net | 567,822 | 571,776 | 578,887 | 586,932 | 606,911 |
| Investments And Advances | 12,297 | 27,795 | 51,256 | 75,428 | 275,958 |
| Intangibles | 2,274,444 | 2,320,682 | 2,339,314 | 2,359,143 | 2,384,045 |
| Other Non-Current Assets | 174,952 | 149,649 | 145,581 | 149,206 | 171,624 |
| TOTAL | $3,029,515 | $3,069,902 | $3,115,038 | $3,170,709 | $3,438,538 |
| Total Assets | $5,086,044 | $4,993,793 | $4,943,612 | $5,086,083 | $5,355,875 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 437,142 | 430,485 | 424,044 | N/A | N/A |
| Accounts payable and accrued liabilities | 57,537 | 67,163 | 50,736 | 56,671 | 86,934 |
| Accrued Expenses | 255,260 | 215,885 | 210,011 | 240,460 | 221,670 |
| Other current liabilities | 32,110 | 38,221 | 29,649 | 61,035 | 54,339 |
| TOTAL | $818,065 | $794,146 | $786,324 | $392,347 | $428,722 |
| Non-Current Liabilities | |||||
| Long Term Debt | 0 | N/A | 0 | 417,400 | 409,723 |
| Deferred Revenues | 20,802 | 19,845 | 17,077 | 18,369 | 17,992 |
| Other Non-Current Liabilities | 191,107 | 196,018 | 194,975 | 193,956 | 197,954 |
| TOTAL | $198,582 | $223,282 | $234,927 | $695,777 | $739,868 |
| Total Liabilities | $1,016,647 | $1,017,428 | $1,021,251 | $1,088,124 | $1,168,590 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 136,167 | 135,407 | 135,057 | 135,372 | 137,793 |
| Common Shares | 135 | 135 | 135 | 136 | 140 |
| Retained earnings | 1,126,308 | 1,074,472 | 1,046,835 | 1,137,266 | 1,347,790 |
| Other shareholders' equity | -6,963 | -11,851 | -11,045 | -10,192 | -18,736 |
| TOTAL | $4,069,397 | $3,976,365 | $3,922,361 | $3,997,959 | $4,187,285 |
| Total Liabilities And Equity | $5,086,044 | $4,993,793 | $4,943,612 | $5,086,083 | $5,355,875 |